E-LIB Suche - Ergebnisse für: Veng‐Pedersen, P.

1

The effect of anticoagulant, storage temperature and diluti..:

FREISE, K. J. ; SCHMIDT, R. L. ; GINGERICH, E. L...
International Journal of Laboratory Hematology. 31 (2009) 5 - p. 496-504 , 2009

Link: https://doi.org/10.1111/..

2

A 'bottom‐up' approach for endo‐PK/PD analysis:

Neelakantan, S. ; Widness, J.A. ; Schmidt, R.L..
Biopharmaceutics & Drug Disposition. 27 (2006) 7 - p. 313-327 , 2006

Link: https://doi.org/10.1002/..

3

Pharmacokinetic/pharmacodynamic insulin‐glucose analysis fo..:

Gupta, N. ; Hoffman, R.P. ; Veng‐Pedersen, P.
Biopharmaceutics & Drug Disposition. 27 (2006) 6 - p. 257-265 , 2006

Link: https://doi.org/10.1002/..

4

Pharmacokinetic tracer kinetics analysis of changes in eryt..:

Veng‐Pedersen, P. ; Chapel, S. ; Al‐Huniti, N.H....
Biopharmaceutics & Drug Disposition. 25 (2004) 4 - p. 149-156 , 2004

Link: https://doi.org/10.1002/..

5

Erythropoietin production rate in phlebotomy‐induced acute ..:

Al‐Huniti, N.H. ; Widness, J.A. ; Schmidt, R.L..
Biopharmaceutics & Drug Disposition. 25 (2004) 9 - p. 389-397 , 2004

Link: https://doi.org/10.1002/..

6

Kinetic Evaluation of Nonlinear Drug Elimination by a Dispo..:

Veng‐Pedersen, P. ; Widness, J.A. ; Pereira, L.M....
Journal of Pharmaceutical Sciences. 84 (1995) 6 - p. 760-767 , 1995

Link: https://doi.org/10.1002/..

7

Absorption and disposition characteristics of nitrofurantoi..:

Niazi, S. ; Vishnupad, K. S. ; Veng‐Pedersen, P.
Biopharmaceutics & Drug Disposition. 4 (1983) 3 - p. 213-223 , 1983

Link: https://doi.org/10.1002/..

8

A Bayesian population analysis of the development of type 2..:

Lin, C. W. ; Warram, J. H. ; Veng-Pedersen, P.
Journal of Pharmacokinetics and Pharmacodynamics. 38 (2011) 5 - p. 563-579 , 2011

Link: https://doi.org/10.1007/..

9

Change in Erythropoietin Pharmacokinetics Following Hematop..:

Widness, J A ; Schmidt, R L ; Hohl, R J...
Clinical Pharmacology & Therapeutics. 81 (2007) 6 - p. 873-879 , 2007

Link: https://doi.org/10.1038/..

10

Individualized pharmacokinetic risk assessment for developm..:

Gupta, N. ; Al-Huniti, N.H. ; Veng-Pedersen, P.
Diabetes Research and Clinical Practice. 78 (2007) 1 - p. 93-101 , 2007

Link: https://doi.org/10.1016/..

11

Pharmacokinetic/pharmacodynamic differentiation of pancreat..:

Gupta, N. ; Hoffman, R. P. ; Veng-Pedersen, P.
Biopharmaceutics & Drug Disposition. 26 (2005) 7 - p. 287-294 , 2005

Link: https://doi.org/10.1002/..

12

Determination of drug absorption rate in time-variant dispo..:

Neelakantan, S. ; Veng-Pedersen, P.
Biopharmaceutics & Drug Disposition. 26 (2005) 8 - p. 353-370 , 2005

Link: https://doi.org/10.1002/..

13

Noncompartmentally-based pharmacokinetic modeling:

Veng-Pedersen, P
Advanced Drug Delivery Reviews. 48 (2001) 2-3 - p. 265-300 , 2001

Link: https://doi.org/10.1016/..

14

Carbamazepine level-Ain vivo-in vitro correlation (IVIVC): ..:

Veng-Pedersen, P. ; Gobburu, J.V.S. ; Meyer, M.C..
Biopharmaceutics & Drug Disposition. 21 (2000) 1 - p. 1-6 , 2000

Link: https://doi.org/10.1002/..

15

A comparison of nonlinear pharmacokinetics of erythropoieti..:

Veng-Pedersen, P. ; Widness, J.A. ; Pereira, L.M...
Biopharmaceutics & Drug Disposition. 20 (1999) 4 - p. 217-223 , 1999

Link: https://doi.org/10.1002/..